Entertainment Arts (EARI) 0.0035 $EARI New Factors Move

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Entertainment Arts (EARI) 0.0035 $EARI

New Factors Move a Trending Market - Analyst Comments on Entertainment Arts Research, Danone, Nissan Motor and Alkaline Water Company
ACCESSWIRE - Fri Mar 11, 7:10AM CST
NEW YORK, NY / ACCESSWIRE / March 11, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Entertainment Arts Research Inc. (OTC: EARI), Danone SA (OTC: DANOY), Nissan Motor Co. Ltd. (OTC: NSANY) and Alkaline Water Company Inc. (OTC: WTER). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Small Cap Stocks Take Aim At Fourth Quarter
ACCESSWIRE - Mon Sep 28, 6:32AM CDT
CORAL GABLES, FL / ACCESSWIRE / September 28, 2015 / Higher market volatility has brought rise to much more uncertainty when it comes to finding investment opportunity for investors & traders alike. As many have noted, foreign instability and lower interest rates remaining in place have been previous catalysts to conclusively leading investors down the path of smaller capitalization value investments. With the US economy strengthening, emerging companies have an opportunity to take advantage of the business climate. With three quarters nearly behind us, the fourth quarter has given rise to many of these small cap companies zeroing in on finishing 2015 strong. Companies like Maxima Group (PINKSHEETS: MXMG), Entertainment Arts Research Group, Inc. (PINKSHEETS: EARI), and Enviro-Serv Inc. (PINKSHEETS: EVSV) have found themselves working to increase the size of their respective operational footprints in order to build upon market momentum gained earlier in the year.

Tech Stocks Hold Leading Role After Recent Market Turn Around
ACCESSWIRE - Wed Sep 16, 6:30AM CDT
CORAL GABLES, FL / ACCESSWIRE / September 16, 2015 / The Fed minutes aren't the only thing being talked about in the market. Tech stocks have helped to lead a day of strong buying on Wall Street during Tuesday's session. This marked the last full day of trading prior to what will be an intently watched meeting of the Federal Reserve's interest-rate-setting Open Market Committee. Even the tech-focused Nasdaq composite index rose by 1.14%, to 4,860.52 up another 54.76.

Entertainment Arts Research Shareholder Update
PR Newswire - Fri Aug 28, 8:20AM CDT
Entertainment Arts Research Inc. (OTC: EARI) has posted its second quarter financials. The third quarter financials will include the information of the purchase of GoLoyal which closed in July. EARI is actively pursuing other acquisitions to strengthen its core services in web design, social media marketing and SEO optimization. "We are in the first stages of talks with several companies right now," Mark Gibbs, President of EARI stated, "The companies we are talking to are all leaders in the their industry. They are attracted to being part of EARI because our vision encompasses where technology and informational marketing is headed. We are going to be a family of companies that not only provide services for a company to sell in social media but we will be one of the few that will be able to manage the entire business brand and its sales cycle. EARI is looking at filling a tremendous void of having a company not only design and optimize your website, but will also be able to coordinate our Client's message in social and traditional marketing campaigns to deliver maximum and consistent brand recognition for a greater customer experience. We will provide our Clients with a suite of tools to manage the efficiency of their marketing and brand recognition efforts."

Small Cap Stocks Lead the Charge for Market Trend Reversal
ACCESSWIRE - Fri Aug 28, 6:30AM CDT
CORAL GABLES, FL / ACCESSWIRE / August 28, 2015 / The last week has been turbulent as major indexes have entered deep into correction territory. During the last five years the Dow has only seen four occurrences when closing losses hit 400 points or more in a single session. Last Friday the Nasdaq lost over 3% and joined the other major averages in negative territory for 2015.

Entertainment Arts Research offers new GoLoyal services
M2 - Thu Aug 13, 9:12AM CDT
Entertainment Arts Research, Inc. said its technology marketing company GoLoyal will now offer text-messaging services for its clients. GoLoyal offers email marketing and social marketing campaigns for companies to attract, retain and expand customer satisfaction.

Entertainment Arts Research, Inc. Announces New Services For GoLoyal
PR Newswire - Wed Aug 12, 7:00AM CDT
Entertainment Arts Research, Inc. (EARI) is pleased to announce that its Technology marketing company GoLoyal will now offer text-messaging services for its clients. GoLoyal offers email marketing and social marketing campaigns for companies to attract, retain and expand customer satisfaction.

Entertainment Arts Research Inc. Announces Corporate Update And Business Outlook For Second Half of 2015
PR Newswire - Mon Jul 27, 6:30AM CDT
Entertainment Arts Research Inc. (OTC:EARI), a company that provides services and products that educate, inform and entertain is pleased to give a corporate update and business outlook for the rest of the third quarter of 2015.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 655

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 83

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

VivoPower Innovates with XRP-Focused Treasury Strategy

Updated Category News Views 359

VivoPower's Transformational XRP Strategy VivoPower International PLC (NASDAQ: VVPR) has recently embarked on a groundbreaking journey by announcing a new strategy centered on the digital asset XRP. The company is positioning itself as the first publicly traded entity to implement an XRP-focused digital asset treasury. This innovative approach is not only exciting for...

Continue Reading
Recognizing Excellence in Product Stewardship for 2024

Updated Category News Views 114

Celebrating Product Stewardship Excellence The Product Stewardship Society has announced a significant honor for 2024—Lynn L. Bergeson has been named the recipient of the prestigious Allan K. Fleeger Distinguished Service Award. This esteemed award has been established to acknowledge the remarkable contributions of individual product stewards who have played crucial...

Continue Reading
Gold Hits New Heights Amid Tensions and Election Uncertainty

Updated Category News Views 163

Gold Prices Surge to Record Heights In recent trading, gold prices have reached unprecedented levels, reflecting a significant rise driven by various factors, including political uncertainties and ongoing international conflicts. As anticipation surrounding a highly competitive U.S. presidential election grows, along with persistent tensions in regions such as the Middle...

Continue Reading
Paul Jebely Joins Sterlington as Aviation Law Vice Chair

Updated Category News Views 257

Paul Jebely Joins Sterlington as New Partner Sterlington PLLC is excited to announce that Paul Jebely has joined the firm as their new Partner and Vice Chair of International, marking a crucial advancement in their aviation law practice. Jebely is not just any attorney; he is a globally recognized authority in private aviation law, especially known for his work with...

Continue Reading
William James Wartinbee III Executes Significant Sell Strategy

Updated Category News Views 62

William James Wartinbee III Implements Key Sell Strategy In a noteworthy insider sale, William James Wartinbee III, the Executive Vice President at Gartner (IT), has sold 210 shares of the company. This transaction was documented in a Form 4 filing with the U.S. Securities and Exchange Commission, and the sale was valued at about $103,275. Examining Gartner's Current...

Continue Reading